Literature DB >> 11165250

Disulfide bridge reorganization induced by proline mutations in maurotoxin.

E Carlier1, Z Fajloun, P Mansuelle, M Fathallah, A Mosbah, R Oughideni, G Sandoz, E Di Luccio, S Geib, I Regaya, J Brocard, H Rochat, H Darbon, C Devaux, J M Sabatier, M de Waard.   

Abstract

Maurotoxin (MTX) is a 34-residue toxin that has been isolated from the venom of the chactidae scorpion Scorpio maurus palmatus, and characterized. Together with Pi1 and HsTx1, MTX belongs to a family of short-chain four-disulfide-bridged scorpion toxins acting on potassium channels. However, contrary to other members of this family, MTX exhibits an uncommon disulfide bridge organization of the type C1-C5, C2-C6, C3-C4 and C7-C8, versus C1-C5, C2-C6, C3-C7 and C4-C8 for both Pi1 and HsTx1. Here, we report that the substitution of MTX proline residues located at positions 12 and/or 20, adjacent to C3 (Cys(13)) and C4 (Cys(19)), results in conventional Pi1- and HsTx1-like arrangement of the half-cystine pairings. In this case, this novel disulfide bridge arrangement is without obvious incidence on the overall three-dimensional structure of the toxin. Pharmacological assays of this structural analog, [A(12),A(20)]MTX, reveal that the blocking activities on Shaker B and rat Kv1.2 channels remain potent whereas the peptide becomes inactive on rat Kv1.3. These data indicate, for the first time, that discrete point mutations in MTX can result in a marked reorganization of the half-cystine pairings, accompanied with a novel pharmacological profile for the analog.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165250     DOI: 10.1016/s0014-5793(00)02433-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Protein folding determinants: structural features determining alternative disulfide pairing in alpha- and chi/lambda-conotoxins.

Authors:  Tse Siang Kang; Zoran Radić; Todd T Talley; Seetharama D S Jois; Palmer Taylor; R Manjunatha Kini
Journal:  Biochemistry       Date:  2007-02-22       Impact factor: 3.162

Review 2.  Structural determinants of protein folding.

Authors:  Tse Siang Kang; R Manjunatha Kini
Journal:  Cell Mol Life Sci       Date:  2009-04-15       Impact factor: 9.261

3.  Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels.

Authors:  Wei Fu; Meng Cui; James M Briggs; Xiaoqin Huang; Bing Xiong; Yingmin Zhang; Xiaomin Luo; Jianhua Shen; Ruyun Ji; Hualiang Jiang; Kaixian Chen
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

4.  Parameters affecting in vitro oxidation/folding of maurotoxin, a four-disulphide-bridged scorpion toxin.

Authors:  E di Luccio; D O Azulay; I Regaya; Z Fajloun; G Sandoz; P Mansuelle; R Kharrat; M Fathallah; L Carrega; E Estève; H Rochat; M De Waard; J M Sabatier
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

5.  Solution structure of Pi4, a short four-disulfide-bridged scorpion toxin specific of potassium channels.

Authors:  J Iñaki Guijarro; Sarrah M'Barek; Froylan Gómez-Lagunas; Damien Garnier; Hervé Rochat; Jean-Marc Sabatier; Lourival Possani; Muriel Delepierre; Lourrival Possani
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

6.  Toxinology provides multidirectional and multidimensional opportunities: A personal perspective.

Authors:  R Manjunatha Kini
Journal:  Toxicon X       Date:  2020-05-11

7.  An intermediate-effect size variant in UMOD confers risk for chronic kidney disease.

Authors:  Eric Olinger; Céline Schaeffer; Kendrah Kidd; Elhussein A E Elhassan; Yurong Cheng; Inès Dufour; Guglielmo Schiano; Holly Mabillard; Elena Pasqualetto; Patrick Hofmann; Daniel G Fuster; Andreas D Kistler; Ian J Wilson; Stanislav Kmoch; Laure Raymond; Thomas Robert; Kai-Uwe Eckardt; Anthony J Bleyer; Anna Köttgen; Peter J Conlon; Michael Wiesener; John A Sayer; Luca Rampoldi; Olivier Devuyst
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-10       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.